Legonucleotides for detection

Chem2Sense aims to revolutionize biosensor development by creating high-affinity aptalegomers through reversible aptamer conjugation and advanced nanopore sequencing techniques.

Subsidie
€ 1.999.144
2024

Projectdetails

Introduction

Sensors have a vital importance on human life, detecting diseases or contaminants that endanger the environment. A widely pursued challenge has been to develop universal biosensors with the flexibility to detect molecules regardless of their size.

Challenges with Current Solutions

Antibodies have been used to fulfill this aim, but single-stranded oligonucleotides (aptamers) interact efficiently with targets and have also been proposed as an alternative. However, aptamers lack the ability for versatile functionalization to tune affinities, and they suffer from highly complex selection and identification.

Proposed Approach

Chem2Sense proposes an interdisciplinary approach to overcome these obstacles. My hypothesis is that a new strategy based on the reversible conjugation of aptamers with small molecules will remove barriers in designing universal biosensors.

Objectives of Chem2Sense

Chem2Sense aims to redesign the aptamer concept with flexible oligolegonucleotides and a cutting-edge nanopore sequencing methodology. The two objectives will be:

  1. To develop chemically modified nucleotides as lego-bricks to build high-affinity aptalegomers.
  2. To develop a ground-breaking sequencing methodology using artificial intelligence to boost aptalegomer identification.

Methodology

The proposed legonucleotides are synthetic nucleotides that reversibly attach small molecules in a dynamic combinatorial library. After challenging a vast library against a target, a Darwinian chemical selection will occur, leading to the best fit, the aptalegomer, a high-affinity oligonucleotide of natural and conjugated legonucleotides.

Conclusion

Therefore, the objective of Chem2Sense is to create a ground-breaking methodology that overcomes significant obstacles in aptamers development, providing a powerful synergy between novel chemical aptalegomers generation and a direct method for selection/identification using the latest advances in oligonucleotide sequencing. Chem2Sense will bring highly sensitive and versatile aptalegomers to a broad range of vital applications.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.999.144
Totale projectbegroting€ 1.999.144

Tijdlijn

Startdatum1-9-2024
Einddatum31-8-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICASpenvoerder

Land(en)

Spain

Vergelijkbare projecten binnen European Research Council

ERC Consolid...

Development of Suprasensors and Assays for Molecular Diagnostics

SupraSense aims to develop advanced biomimetic sensors for detecting metabolites in biofluids, enhancing diagnostic selectivity and sensitivity for early disease detection.

€ 1.994.069
ERC Starting...

Biosensing by Sequence-based Activity Inference

This project aims to develop a data-driven pipeline for engineering genetically encoded biosensors to enhance molecule detection and support sustainable bioprocesses in synthetic biology.

€ 1.499.453
ERC Proof of...

High throughput development platform for oligonucleotide aptamers

SPARXS is an innovative platform that enables rapid design of affinity probes by simultaneously analyzing binding kinetics and sequences of millions of aptamers for diverse applications.

€ 150.000
ERC Proof of...

Novel ApameR-Based Rapid Test Technology for Virus Detection

Developing a cost-effective RNA aptamer-based sensor for rapid point-of-care testing of avian influenza, meeting WHO ASSURED criteria, to enhance pathogen detection and containment.

€ 150.000
ERC Advanced...

Protein function regulation through inserts for response to biological, chemical and physical signals

This project aims to develop a modular platform for engineering proteins to sense and respond to diverse signals, enhancing their functionality for innovative biomedical applications.

€ 2.500.000

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Computation driven development of novel vivo-like-DNA-nanotransducers for biomolecules structure identification

This project aims to develop DNA-nanotransducers for real-time detection and analysis of conformational changes in biomolecules, enhancing understanding of molecular dynamics and aiding drug discovery.

€ 3.000.418
EIC Pathfinder

integrated nano-photonic OMICs bio-SENSor for lung cancer

OMICSENS aims to develop a novel nano-photonic omics bio-sensor for real-time detection of TKI resistance in NSCLC, enhancing prognosis and paving the way for personalized cancer treatment.

€ 2.372.318
EIC Pathfinder

Versatile Amplification Method for Single-Molecule Detection in Liquid Biopsy

VerSiLiB aims to develop an enzyme-free amplification platform for detecting proteins and nucleic acids in liquid biopsies, enhancing cancer management through novel affinity-mediated transport.

€ 2.994.244
EIC Pathfinder

Universal GPCR Activity Sensor for Next Generation Drug Discovery

This project aims to develop a novel single-assay technology platform for GPCR drug discovery, enhancing detection and classification of drug candidates to improve efficacy and reduce failures.

€ 2.965.384
EIC Accelerator

Transforming Molecular Diagnostics through NanoTechnology

Altratech Ltd aims to revolutionize molecular diagnostics by using patented nanotechnology for rapid, non-clinical detection of viruses and pathogens without biological amplification.

€ 2.499.999